Literature DB >> 23677176

Changes in third ventricular size in pediatric patients undergoing endoscopic third ventriculostomy.

Jonathan Pindrik1, George I Jallo, Edward S Ahn.   

Abstract

PURPOSE: Optimal methods of evaluating radiographic data following endoscopic third ventriculostomy (ETV) are not yet known. This study analyzes imaging parameters, including third ventricular width and cross-sectional area (CSA), in pediatric ETV patients.
METHODS: Hydrocephalic pediatric patients treated by ETV at the senior authors' institution from 2004 to 2011 were stratified clinically (successful versus unsuccessful outcome) and retrospectively reviewed. Measured from pre- and post-operative imaging studies, third ventricular parameters included maximal width and mid-sagittal CSA, while lateral ventricular parameters included the ratio of greatest frontal horn width to co-linear skull internal diameter and the frontal-occipital horn ratio.
RESULTS: Ten successful ETV patients (mean age 10.6 years; range 11 months to 19.8 years) obtained imaging at least 2.75 months following surgery, while four unsuccessful ETV patients (mean age 9.8 years; range 4 months to 17.3 years) underwent imaging before repeat intervention. Third ventricular width showed an average decline of 0.32 cm and 17.4 % in the successful ETV cohort, but average increases of 0.35 cm and 21.0 % in the ETV failure group. Successful ETV patients exhibited mean decreases of 1.85 cm(2) and 19.7 % in third ventricular mid-sagittal CSA, while unsuccessful ETV patients showed mean increases of 1.17 cm(2) and 17.3 % per patient. These differences were statistically significant. Measures of lateral ventricular size showed similar trends, but with lower magnitude.
CONCLUSIONS: Third ventricular imaging parameters (width and mid-sagittal CSA) exhibited more pronounced responses to ETV than lateral ventricular measurements in pediatric hydrocephalic patients.

Entities:  

Mesh:

Year:  2013        PMID: 23677176     DOI: 10.1007/s00381-013-2145-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  12 in total

1.  Changes in third ventricular size with neuroendoscopic third ventriculostomy: a blinded study.

Authors:  N Buxton; B Turner; N Ramli; M Vloeberghs
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

2.  Imaging correlates of successful endoscopic third ventriculostomy.

Authors:  A V Kulkarni; J M Drake; D C Armstrong; P B Dirks
Journal:  J Neurosurg       Date:  2000-06       Impact factor: 5.115

3.  Measurement of ventricular size: reliability of the frontal and occipital horn ratio compared to subjective assessment.

Authors:  A V Kulkarni; J M Drake; D C Armstrong; P B Dirks
Journal:  Pediatr Neurosurg       Date:  1999-08       Impact factor: 1.162

4.  Endoscopic third ventriculostomy: an outcome analysis of primary cases and procedures performed after ventriculoperitoneal shunt malfunction.

Authors:  Donncha F O'Brien; Mohsen Javadpour; David R Collins; Pietro Spennato; Conor L Mallucci
Journal:  J Neurosurg       Date:  2005-11       Impact factor: 5.115

5.  Ventricular volume following third ventriculostomy.

Authors:  T H Schwartz; B Ho; C J Prestigiacomo; J N Bruce; N A Feldstein; R R Goodman
Journal:  J Neurosurg       Date:  1999-07       Impact factor: 5.115

6.  Functional analysis of third ventriculostomy patency by quantification of CSF stroke volume by using cine phase-contrast MR imaging.

Authors:  Núria Bargalló; Lourdes Olondo; Ana I Garcia; Sebastian Capurro; Luis Caral; Jordi Rumia
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

7.  Flexible endoneurosurgical therapy for aqueductal stenosis.

Authors:  K Oka; M Yamamoto; K Ikeda; M Tomonaga
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

8.  Changes in ventricular volume in hydrocephalic children following successful endoscopic third ventriculostomy.

Authors:  Edward St George; Kal Natarajan; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2004-06-25       Impact factor: 1.475

9.  Changes in intracranial CSF distribution after ETV.

Authors:  Federico Di Rocco; David Grevent; James M Drake; Nathalie Boddaert; Stephanie Puget; Thomas Roujeau; Thomas Blauwblomme; Michel Zerah; Francis Brunelle; Christian Sainte-Rose
Journal:  Childs Nerv Syst       Date:  2012-05-16       Impact factor: 1.475

10.  Frontal and occipital horn ratio: A linear estimate of ventricular size for multiple imaging modalities in pediatric hydrocephalus.

Authors:  B B O'Hayon; J M Drake; M G Ossip; S Tuli; M Clarke
Journal:  Pediatr Neurosurg       Date:  1998-11       Impact factor: 1.162

View more
  5 in total

1.  Prediction of endoscopic third ventriculostomy (ETV) success with 3D-SPACE technique.

Authors:  Oktay Algin
Journal:  Neurosurg Rev       Date:  2014-12-17       Impact factor: 3.042

Review 2.  Ventricular endoscopy in the pediatric population: review of indications.

Authors:  Omar Choudhri; Abdullah H Feroze; Jay Nathan; Samuel Cheshier; Raphael Guzman
Journal:  Childs Nerv Syst       Date:  2014-08-01       Impact factor: 1.475

3.  Radiographic markers of clinical outcomes after endoscopic third ventriculostomy with choroid plexus cauterization: cerebrospinal fluid turbulence and choroid plexus visualization.

Authors:  Jonathan Pindrik; Brandon G Rocque; Anastasia A Arynchyna; James M Johnston; Curtis J Rozzelle
Journal:  J Neurosurg Pediatr       Date:  2016-05-13       Impact factor: 2.375

4.  Stented endoscopic third ventriculostomy—indications and results.

Authors:  Matthias Schulz; Birgit Spors; Ulrich-Wilhelm Thomale
Journal:  Childs Nerv Syst       Date:  2015-06-17       Impact factor: 1.475

Review 5.  Endoscopic third ventriculostomy with/without choroid plexus cauterization for hydrocephalus due to hemorrhage, infection, Dandy-Walker malformation, and neural tube defect: a meta-analysis.

Authors:  Anthony Zandian; Matthew Haffner; James Johnson; Curtis J Rozzelle; R Shane Tubbs; Marios Loukas
Journal:  Childs Nerv Syst       Date:  2013-12-28       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.